🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07120672
Recruiting Observational

PPI in Weaning Prediction

NCT07120672 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-05-08
Last updated
2025-08-13

Condition(s) studied

Perfusion IndexWeaning of Mechanical VentilationICU

Investigational drug(s) / intervention(s)

patients were monitored for reentubation for 48 hours.weaning group

patients were monitored for reentubation for 48 hours.: patients were monitored for reentubation for 48 hours.

weaning group: patients were monitored for reentubation for 48 hours.

Study summary

The aim of this study is to evaluate the predictive role of the Peripheral Perfusion Index (PPI) in forecasting extubation success during the weaning process in intensive care unit (ICU) patients. The study will investigate the ability of PPI to predict extubation failure by comparing it with traditional weaning criteria, including the Rapid Shallow Breathing Index (RSBI), PaO₂/FiO₂ ratio, and respiratory rate.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who have been on mechanical ventilation for at least 48 hours * Patients over 18 years of age who are planned to undergo extubation following a spontaneous breathing trial (SBT) * Patients or their legal representatives who provide informed consent to participate in the study Exclusion Criteria: * Patients for whom extubation is not planned due to hemodynamic instability * Patients with peripheral vascular disease or a history of hand surgery * Patients who die or cannot be followed up during the study period

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Gaziosmanpaşa Training and Research Hospital Istanbul Turkey (Türkiye) Recruiting

More Gaziosmanpasa Research and Education Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07120672 on ClinicalTrials.gov ↗ ← All trials in Turkey